Ocera Therapeutics, Inc. OCRX
No live quote for OCRX yet.
OCRX revenue history
Revenue is income from the company’s ordinary business activities.
609,000 USD
FY 2016 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2016 | 2016-12-31 | 609,000 | 476,000 | 357.89% |
| FY 2015 | 2015-12-31 | 133,000 | -208,000 | -61.00% |
| FY 2014 | 2014-12-31 | 341,000 | 256,000 | 301.18% |
| FY 2013 | 2013-12-31 | 85,000 | 85,000 | Not meaningful |
| FY 2012 | 2012-12-31 | 0 | -10,167,000 | -100.00% |
| FY 2011 | 2011-12-31 | 10,167,000 | 1,629,000 | 19.08% |
| FY 2010 | 2010-12-31 | 8,538,000 | 7,810,000 | 1072.80% |
| FY 2009 | 2009-12-31 | 728,000 | 371,000 | 103.92% |
| FY 2008 | 2008-12-31 | 357,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:02:55.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.